Search

everythinglearnresearchcommunity

for

Search:↓

Intralesional triamcinolone acetonide can regrow hair in alopecia areata but often has temporary effects and side effects.

Some treatments like methotrexate with prednisone might help juvenile morphea, but more research is needed to confirm.

DHEA may help with sexual function when used intravaginally by menopausal women but is similar to hormone therapy in other aspects and might cause more side effects like acne and hair loss.

The review highlights the need for more research on transgender dermatology, the role of dermatologists in gender affirmation, and the effects of hormone therapy on skin and hair.

The 2018 update to the ED care model added a new severity score and stressed a detailed evaluation of both physical and psychological aspects.

Hair loss can lead to significant stigma and lower quality of life, especially for women and those with certain types of alopecia.

Unwanted facial hair significantly impacts over 40% of women's psychological and social well-being, and various treatment options are available.

The article concludes that correctly diagnosing systemic causes of hair loss requires a detailed clinical evaluation and a systematic diagnostic approach.

Low-Level Laser Therapy may help with flap survival and burn scar healing, but not with venous ulcers or hair loss, and more research is needed.

The conclusion is that while oral contraceptive pills are effective for PCOS-related high androgen levels, new treatments with fewer side effects are needed.

Rivaroxaban can cause liver injury, allergic reactions, blood vessel inflammation, and hair loss, but these side effects are rare.

Men using hair loss drugs like finasteride may experience sexual side effects like erectile dysfunction, but it's unclear who will be affected and when. Treating depression and sexual symptoms is suggested, as these men often have higher rates of both. More research is needed to understand why these side effects occur.

Levetiracetam often causes behavioral issues, while oxcarbazepine is more likely to cause sleepiness in epilepsy patients.

Most women with PCOS use positive coping strategies, but some with more psychological stress use negative ones.

Finasteride may cause side effects; more research needed.

Chitosan-based dressings reduce inflammation and speed up skin wound healing.

Finasteride helps hair growth but may cause sexual side effects and depression.

Hormone therapy increases facial and body hair in transgender men, while hair removal improves well-being in transgender women, but cost is a barrier as insurance often doesn't cover it. Dermatologists can use various treatments for these hair issues.

Case reports are important in medical science for discovering drugs and identifying rare conditions, despite their limitations.

Saw palmetto may improve urinary symptoms with fewer sexual side effects compared to some medications.

Women with PCOS often have sexual problems, and treating these issues early can improve satisfaction and reduce healthcare costs.

Taking vitamin B6 corrected a pregnant woman's metabolic disorder, which changed her hair color.

More research is needed to find the best treatment for dissecting cellulitis of the scalp.

The document recommends three dermatology books for their valuable content on evidence-based medicine, comprehensive treatment descriptions, and updated information on hair and scalp disorders.

Mesotherapy is a promising alternative to minoxidil for hair loss with mild side effects.

Hyperandrogenism increases heart disease risk in premenopausal women, but this risk is linked to obesity in postmenopausal women.

Terbinafine is the most effective treatment for tinea capitis, a scalp infection often confused with other conditions.

The issue included new and updated reviews on various health interventions, with significant findings on weight loss, psychological therapies, cancer treatment, and more.

PSA screening's effectiveness in reducing prostate cancer deaths can vary based on trial design and participant compliance.

Male pattern baldness may predict prostate cancer risk.